Biotech Co. Can't Arbitrate $881M Cannabinoid IP Fight
A New York federal judge on Monday denied biotech company Amyris' bid to arbitrate an $881 million trade secrets fight with cannabinoid manufacturer Lavvan, finding that a prior agreement the parties...To view the full article, register now.
Already a subscriber? Click here to view full article